Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform.
Katharina BeyerVera StratenSebastiaan RemmersSteven MacLennanSara MacLennanGiorgio GandagliaPeter-Paul M WillemseRonald HerreraMuhammad Imran OmarBeth RussellJohannes HuberMarkus KreuzAlex AsiimweTom AbbottAlberto BrigantiMieke Van HemelrijckMonique J Roobolnull The Prias Consortiumnull The Erspc Rotterdam Study Groupnull The Pioneer ConsortiumPublished in: Journal of personalized medicine (2022)
This is one of the first studies comparing the incidence of guideline-recommended treatment changes in men receiving different primary treatments (i.e., AS, RT, or RP) for localized prostate cancer (PCa).